JAK1 inhibitor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for JAK1 inhibitor, covering 2025-12-22 to 2025-12-26. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas [Phase 2]